28.02.2013 Views

How to Withdraw Mechanical Ventilation - American Association of ...

How to Withdraw Mechanical Ventilation - American Association of ...

How to Withdraw Mechanical Ventilation - American Association of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

AACN18_4_397-403 10/20/07 14:23 Page 402<br />

CAMPBELL AACN Advanced Critical Care<br />

patients, 2 patients (6%) survived <strong>to</strong> hospital<br />

discharge, and O’Mahoney et al discharged 3<br />

<strong>of</strong> 21 (14%) patients after ventila<strong>to</strong>r withdrawal.<br />

8,11<br />

Across studies the duration <strong>of</strong> survival<br />

ranged from 2 minutes <strong>to</strong> 9 days after ventila<strong>to</strong>r<br />

withdrawal. Median survival across<br />

studies ranged from 35 minutes 13 <strong>to</strong> 7.5<br />

hours. 9 Campbell et al reported no relationship<br />

between duration <strong>of</strong> survival and use <strong>of</strong><br />

sedation/analgesia, GCS score, or PaO 2/FiO 2<br />

but there was a significant inverse correlation<br />

with illness severity measured with<br />

APACHE II 26 (r ��0.42, P � .05). 8 Mayer<br />

et al also found no relationship between duration<br />

<strong>of</strong> survival and GCS score. 9 Ankrom<br />

et al reported no correlation between analgesia<br />

use and duration <strong>of</strong> survival; however,<br />

patients who died in less than 30 minutes received<br />

an average <strong>to</strong>tal morphine dose <strong>of</strong><br />

206 � 265 mg morphine, and those who<br />

died more than 30 minutes after withdrawal<br />

received an average <strong>of</strong> 78 � 111 mg morphine.<br />

10 This suggests a clinical significance,<br />

although the analysis with a small sample<br />

and a large standard deviation may not have<br />

yielded a statistical significance.<br />

Of note, both Campbell et al and Chan et al<br />

reported no significant relationship between<br />

analgesia/sedation and duration <strong>of</strong> survival. 8,13<br />

<strong>How</strong>ever, with similar average reported GCS<br />

scores (5.3 vs 4), Campbell reported an average<br />

<strong>to</strong>tal morphine dose <strong>of</strong> 36 mg for the 24hour<br />

period after withdrawal and an average<br />

survival <strong>of</strong> 24.2 hours (median 2.3 hours).<br />

This contrasts sharply with the average <strong>to</strong>tal<br />

morphine dose <strong>of</strong> 81 mg for the 24-hour period<br />

before death and the median survival after<br />

ventila<strong>to</strong>r withdrawal <strong>of</strong> 35 minutes<br />

(range, 1 minute <strong>to</strong> 14.8 hours).<br />

Summary<br />

Small samples and largely retrospective chart<br />

reviews characterize the body <strong>of</strong> evidence<br />

about processes for ventila<strong>to</strong>r withdrawal.<br />

Thus, it seems fair <strong>to</strong> say that the evidence is<br />

largely lacking <strong>to</strong> predict the best method that<br />

ensures patient comfort without hastening<br />

death. Palliation versus hastening death may<br />

be difficult <strong>to</strong> distinguish in this context because<br />

the patients are <strong>of</strong>ten near death before<br />

the ventila<strong>to</strong>r is withdrawn. The cited research<br />

is not conclusive <strong>to</strong> make recommendations<br />

in all cases <strong>of</strong> ventila<strong>to</strong>r withdrawal.<br />

Therefore, a number <strong>of</strong> suggested processes<br />

402<br />

may be useful in this clinical context as well as<br />

with a team approach <strong>to</strong> the procedure and<br />

patient care.<br />

First, a common measure <strong>of</strong> dyspnea or respira<strong>to</strong>ry<br />

distress should be identified and used<br />

across clinicians <strong>to</strong> guide the initiation and escalation<br />

<strong>of</strong> opioids or sedatives, such as noting<br />

the presence <strong>of</strong> behaviors specific <strong>to</strong> respira<strong>to</strong>ry<br />

distress. Additionally, moni<strong>to</strong>ring the patient<br />

for signs <strong>of</strong> affective distress, such as fear,<br />

is essential. Brain-dead patients do not experience<br />

or display signs <strong>of</strong> distress.<br />

Premedication or medication during and<br />

following withdrawal <strong>of</strong> mechanical ventilation<br />

with opioids and benzodiazepines is<br />

useful if the patient is experiencing distress<br />

before withdrawal or likely <strong>to</strong> experience distress<br />

during or after. Brain-dead patients do<br />

not require medication because there is no<br />

distress. Coma<strong>to</strong>se patients may require little<br />

or no analgesia or sedation unless objective<br />

signs <strong>of</strong> respira<strong>to</strong>ry distress are apparent.<br />

Doses should be initiated according <strong>to</strong> the patient’s<br />

<strong>to</strong>lerance and escalated only <strong>to</strong> signs or<br />

reports <strong>of</strong> distress.<br />

Every attempt should be made <strong>to</strong> extubate<br />

patients after ceasing mechanical ventilation<br />

because the endotracheal tube is a source <strong>of</strong><br />

iatrogenic discomfort. <strong>How</strong>ever, in some<br />

cases, particularly when the patient is unresponsive,<br />

it may be best <strong>to</strong> keep the endotracheal<br />

tube, such as when the <strong>to</strong>ngue is<br />

swollen, when gag and cough reflexes are absent,<br />

or when there is a large volume <strong>of</strong> pulmonary<br />

secretions. Studies are needed <strong>to</strong> identify<br />

best methods.<br />

References<br />

1. Meisel A. The legal consensus about forgoing life-sustaining<br />

treatment: its status and its prospects. Kennedy<br />

Inst Ethics J. 1993;2:309–335.<br />

2. President’s Commission for the Study <strong>of</strong> Ethical Problems<br />

in Medicine and Behavioral Research. Deciding <strong>to</strong><br />

Forego Life-Sustaining Treatment. Washing<strong>to</strong>n, DC: US<br />

Government Printing Office; 1983.<br />

3. Omnibus Budget Reconciliation Act. Washing<strong>to</strong>n, DC:<br />

Government Printing Office; 1990.<br />

4. Grenvik A. “Terminal weaning”: discontinuance <strong>of</strong> lifesupport<br />

therapy in the terminally ill patient. Crit Care<br />

Med. 1983;11:394–395.<br />

5. Rubenfeld GD, Crawford SW. Principles and practice <strong>of</strong><br />

withdrawing life-sustaining treatment in the ICU. In:<br />

Curtis JR, Rubenfeld GD, eds. Managing Death in the<br />

ICU: The Transition From Cure <strong>to</strong> Comfort. New York:<br />

Oxford University Press; 2001:127–147.<br />

6. Faber-Langendoen K, Bartels DM. Process <strong>of</strong> forgoing<br />

life-sustaining treatment in a university hospital: an empirical<br />

study. Crit Care Med. 1992;20(5):570–577.<br />

7. Daly BJ, Thomas D, Dyer MA. Procedures used in withdrawal<br />

<strong>of</strong> mechanical ventilation. Am J Crit Care. 1996;<br />

5:331–338.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!